Corcept Therapeutics Incorporated (CORT) revenue is $207.6M
Corcept Therapeutics Incorporated (CORT) revenue is $207.6M as of 2025-09-30. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full CORT research page for quote, filings, and the rest of the model. This satellite exists so “Corcept Therapeutics Incorporated revenue” can rank with the actual number, then send you to /stock/cort.